# Beam Therapeutics > American healthcare company **Wikidata**: [Q107457363](https://www.wikidata.org/wiki/Q107457363) **Wikipedia**: [English](https://en.wikipedia.org/wiki/Beam_Therapeutics) **Source**: https://4ort.xyz/entity/beam-therapeutics ## Summary Beam Therapeutics operates in the biotechnology industry. ## Summary Beam Therapeutics is an American public healthcare company specializing in biotechnology, particularly known for its focus on precision genetic medicine. It is listed on the Nasdaq stock exchange under the ticker symbol "BEAM" and operates as a joint-stock company with a global presence. ## Key Facts - Beam Therapeutics is a public company, meaning its securities are available for sale to the general public. - It is headquartered in the United States and operates within the biotechnology industry. - The company is listed on the Nasdaq stock exchange under the ticker symbol "BEAM." - Beam Therapeutics has a presence in multiple languages, including English, German, and Persian, as indicated by its Wikipedia sitelinks. - The company is recognized by various identifiers, including a ROR ID (05jqhfh02), GRID ID (grid.511072.0), and a Golden ID (Beam_Therapeutics-4N9J9NW). - It is classified as a company and a public company, distinguishing it from private entities. - Beam Therapeutics has a sitelink count of 3, indicating its presence across different platforms. - The company's official website is https://www.beamtx.com. - It is associated with academic and scientific resources, as evidenced by its Scilit organization ID (100646). ## FAQs **What is Beam Therapeutics?** Beam Therapeutics is an American public healthcare company focused on biotechnology, particularly in the field of precision genetic medicine. It is listed on the Nasdaq stock exchange under the ticker symbol "BEAM." **Where is Beam Therapeutics headquartered?** Beam Therapeutics is headquartered in the United States. **What industry does Beam Therapeutics operate in?** Beam Therapeutics operates within the biotechnology industry, specializing in precision genetic medicine. **Is Beam Therapeutics a public company?** Yes, Beam Therapeutics is a public company, meaning its securities are available for sale to the general public. **What is the stock ticker symbol for Beam Therapeutics?** The stock ticker symbol for Beam Therapeutics is "BEAM," and it is listed on the Nasdaq stock exchange. **What are some identifiers associated with Beam Therapeutics?** Beam Therapeutics is recognized by several identifiers, including a ROR ID (05jqhfh02), GRID ID (grid.511072.0), and a Golden ID (Beam_Therapeutics-4N9J9NW). ## Why It Matters Beam Therapeutics plays a significant role in the biotechnology industry by focusing on precision genetic medicine. This field has the potential to revolutionize healthcare by providing targeted treatments for genetic disorders. As a public company, Beam Therapeutics contributes to the global economy by offering investment opportunities and driving innovation in genetic medicine. ## Notable For - Being a public company listed on the Nasdaq stock exchange under the ticker symbol "BEAM." - Operating within the biotechnology industry with a focus on precision genetic medicine. - Having a global presence, as indicated by its Wikipedia sitelinks in multiple languages. - Being recognized by various identifiers, including ROR ID, GRID ID, and Golden ID. - Contributing to the field of genetic medicine and offering investment opportunities as a public company. ## Body ### Definition and Core Characteristics Beam Therapeutics is an American public healthcare company specializing in biotechnology. As a public company, it offers its securities for sale to the general public, allowing for widespread investment and capital formation. The company is listed on the Nasdaq stock exchange under the ticker symbol "BEAM," which facilitates public trading of its shares. ### Industry and Focus Beam Therapeutics operates within the biotechnology industry, with a particular focus on precision genetic medicine. This field involves the development of targeted treatments for genetic disorders, leveraging advanced genetic technologies to provide personalized healthcare solutions. ### Global Presence and Recognition The company has a global presence, as evidenced by its Wikipedia sitelinks in multiple languages, including English, German, and Persian. This international recognition highlights the company's significance and reach within the biotechnology sector. ### Identifiers and Classification Beam Therapeutics is recognized by several identifiers, including a ROR ID (05jqhfh02), GRID ID (grid.511072.0), and a Golden ID (Beam_Therapeutics-4N9J9NW). These identifiers are used in various academic and scientific resources to track and reference the company. Beam Therapeutics is classified as a company and a public company, distinguishing it from private entities and highlighting its public trading status. ### Stock Exchange and Trading Beam Therapeutics is listed on the Nasdaq stock exchange under the ticker symbol "BEAM." This listing allows the company to raise capital from a wide pool of investors and provides liquidity for shareholders, enabling them to easily buy and sell ownership stakes. ### Official Website and Online Presence The company's official website is https://www.beamtx.com, which serves as a central hub for information about its operations, research, and investment opportunities. Beam Therapeutics also has a presence on various platforms, as indicated by its sitelink count of 3. ### Academic and Scientific Associations Beam Therapeutics is associated with academic and scientific resources, as evidenced by its Scilit organization ID (100646). This association highlights the company's involvement in scientific research and its contributions to the field of biotechnology. ### Governance and Ownership As a public company, Beam Therapeutics is owned by its shareholders, who can be individuals, institutional investors, or other entities that have purchased its publicly traded securities. The company is governed by a board of directors elected by the shareholders, ensuring a separation of ownership and control. ### Regulatory Compliance Beam Therapeutics adheres to strict regulatory disclosure and reporting standards, which promotes transparency for investors. This compliance is essential for maintaining investor confidence and ensuring the company's operations are conducted in a transparent and accountable manner. ## References 1. GRID Release 2021-06-15 2. ROR release v1.0 3. [Source](https://golden.com/wiki/Beam_Therapeutics-4N9J9NW)